• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. INTERSTIM II; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. INTERSTIM II; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE Back to Search Results
Model Number 3058
Device Problems Display or Visual Feedback Problem (1184); Battery Problem (2885)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received from a manufacturer representative regarding a patient who was implanted with an implantable neurostimulator (ins) for unknown indications for use.It was reported that the manufacturer representative inquired about "*" for a new stimulator message on the clinician programmer after they performed a battery test.It was reviewed that for the patient's ins model, it must have gone into a power-on-reset (por).The caller indicated the patient came into the clinic with stimulation on and did not see a por message.The caller was fairly new to the manufacturing company and indicated it must have been the previous representative who encountered the por.The longevity screen change due to por was reviewed and the representative wanted clarification on the best way to calculate longevity.They were advised to use a combination of old and new amplitudes to be conservative.The patient was previously on 3.5 volts on program four and was now at 2.0 volts.No symptoms nor patient complications were reported and troubleshooting resolved the reported issue.
 
Manufacturer Narrative
Correction: b5: event description corrected and resubmitted to include patient's indications for use in first sentence."information was received from a manufacturer representative regarding a patient who was implanted with an implantable neurostimulator (ins) for urinary dysfunction/sacral nerve stimulation and gastrointestinal/pelvic floor." medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
Information was received from a manufacturer representative regarding a patient who was implanted with an implantable neurostimulator (ins) for urinary dysfunction/sacral nerve stimulation and gastrointestinal/pelvic floor.It was reported that the manufacturer representative inquired about "*" for a new stimulator message on the clinician programmer after they performed a battery test.It was reviewed that for the patient's ins model, it must have gone into a power-on-reset (por).The caller indicated the patient came into the clinic with stimulation on and did not see a por message.The caller was fairly new to the manufacturing company and indicated it must have been the previous representative who encountered the por.The longevity screen change due to por was reviewed and the representative wanted clarification on the best way to calculate longevity.They were advised to use a combination of old and new amplitudes to be conservative.The patient was previously on 3.5 volts on program four and was now at 2.0 volts.No symptoms nor patient complications were reported and troubleshooting resolved the reported issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTERSTIM II
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
MDR Report Key11143157
MDR Text Key226014181
Report Number3004209178-2021-00458
Device Sequence Number1
Product Code EZW
UDI-Device Identifier00613994913654
UDI-Public00613994913654
Combination Product (y/n)N
PMA/PMN Number
P970004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 01/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/28/2019
Device Model Number3058
Device Catalogue Number3058
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/07/2021
Initial Date FDA Received01/08/2021
Supplement Dates Manufacturer Received01/08/2021
Supplement Dates FDA Received01/11/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-